Kolberg, Germany

Antje Danielczyk

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 65(Granted Patents)


Location History:

  • Panketal, DE (2015)
  • Kolberg, DE (2012 - 2017)
  • Berlin, DE (2015 - 2024)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Antje Danielczyk: Innovator in Protein Expression Technologies

Introduction

Antje Danielczyk is a prominent inventor based in Kolberg, Germany, known for her significant contributions to the field of biotherapeutics. With a remarkable portfolio of 11 patents, she has been influential in advancing methods for protein production and expression, particularly in the context of human cell usage.

Latest Patents

Among her latest innovations, Danielczyk's notable patents include the "Use of human cells of myeloid leukemia origin for expression of antibodies." This invention outlines a method for producing protein molecule compositions with a defined glycosylation pattern. The process involves introducing nucleic acids into immortalized human blood cells, culturing these cells, and subsequently isolating the resultant protein molecule composition.

Another significant patent is focused on "Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters." This work pertains to recombinant protein production, introducing novel expression cassettes that enhance the expression rates of specific proteins or polypeptides, showcasing her expertise in genetic engineering.

Career Highlights

Throughout her career, Antje Danielczyk has collaborated with esteemed companies such as Glycotope GmbH and Nemod Biotherapeutics GmbH & Co. KG. Her work in these organizations has fostered advancements in biopharmaceuticals, particularly through innovative research approaches and practical applications of her inventions.

Collaborations

Danielczyk has also worked alongside notable colleagues, including fellow researchers Steffen Goletz and Renate Stahn. These collaborations have allowed for the exploration of complex biotechnological challenges, leading to groundbreaking developments in the production of therapeutic proteins.

Conclusion

Antje Danielczyk's contributions to the field of biotechnology and protein expression remain influential. With her innovative patents and collaborations, she continues to pave the way for advancements that hold great potential in the realm of biopharmaceuticals. Her work exemplifies the critical role of inventors in driving innovation and improving therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…